Profil
Dimitris Voliotis is Chief Medical Officer at Radiopharm Theranostics Ltd. since 2024.
Former positions include Senior Vice President-Clinical Development at Zentalis Pharmaceuticals, Inc. from 2020 to 2023, Chief Development Officer at CureVac SE from 2019 to 2020, Global Head-Clinical Development Oncology at Eisai, Inc. from 2016 to 2019, and Vice President & Head-Oncology Group at Bayer HealthCare AG from 2007 to 2014.
Education includes a doctorate from Universität zu Köln.
Aktive Positionen von Dimitris Voliotis
| Unternehmen | Position | Beginn |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 20.08.2024 |
Ehemalige bekannte Positionen von Dimitris Voliotis
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2023 |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Corporate Officer/Principal | 01.02.2020 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01.01.2019 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01.09.2014 |
Ausbildung von Dimitris Voliotis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
















